Elizabeth Weise, USA TODAY

Elizabeth Weise

USA TODAY

San Francisco, CA, United States

Contact Elizabeth

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

Recent:
  • USA TODAY
  • Lansing StateJournal
  • The News Leader
  • The Tennessean
Past:
  • TCPalm
  • The Taunton Gazette
  • Enquirer
  • Times Record News
  • The Columbus Dispatch
  • Silver City Sun-News
  • Alamogordo DailyNews
  • DelmarvaNow!
  • North Jersey News
  • Daily Record
  • and more…

Recent articles by Elizabeth:

CDC-convened panel votes to add nursing home residents to first phase of COVID-19 vaccine rollout

Front-line health care workers are clearly first in line for a COVID-19 vaccine. Then there's the question of who else should be in the initial group. → Read More

CDC-convened committee votes to add nursing home residents to first phase of COVID-19 vaccine access

Everyone in Phase 1a should be able to get the first of the two-shot COVID-19 vaccine series within three weeks of one being authorized by the FDA. → Read More

FAA confirms first 'mass air shipment' of Pfizer's COVID-19 vaccine from Belgium as US preps for distribution

While it can't be delivered to doctors, Pfizer's vaccine can be prepositioned at distribution sites to allow for quicker delivery upon authorization. → Read More

How long will it take for COVID-19 vaccine to be authorized? FDA Commissioner Stephen Hahn answers common questions

Food and Drug Administration Commissioner Dr. Stephen Hahn discussed the vaccine approval process and how the FDA will evaluate immunization safety. → Read More

When could the first COVID-19 vaccines be given in the US?

Given the regulatory timeline, Dec. 13 is the earliest the first round of vaccine against the coronavirus could start to be given to select Americans. → Read More

COVID-19 vaccines are almost ready to be distributed. Who gets them after health care workers? Here's a list.

When a COVID-19 vaccine is ready , people who risk their lives to care for the sick will be first in line to get one. Here's a list of who's next. → Read More

COVID vaccine candidate from Pfizer must be stored at minus 112, prompting a rush on dry ice

At minus 112, exposed skin freezes almost instantly. It’s also the temperature required to store what’s expected to be the first COVID-19 vaccine. → Read More

USA TODAY vaccine panel: 'Best news so far' in COVID-19 fight, but logistical challenges remain

Expert panel pushes USA TODAY's COVID-19 vaccine clock ahead on positive news, but logistical challenges loom in getting doses to Americans. → Read More

Do you trust FDA on COVID-19 vaccines? States and a Black medical group form review boards for second opinion

Five states and an Black medical group say they’ll conduct independent verification of any COVID-19 vaccines that are approved by FDA. → Read More

Biden's approach to tackling COVID-19 will be dramatically different, and quickly apparent

Joe Biden's administration will put science and communication first in battling the COVID-19 pandemic, health experts say, but still faces challenges. → Read More

USA TODAY's experts say securing a COVID-19 vaccine in record time could be easy, but distributing it won't be

Our panel of experts expects at least one COVID-19 vaccine will be approved in the coming months. Then things could really get complicated. → Read More

Half a million deaths by the end of February? Current COVID-19 strategies have the US headed in that direction, experts say

Researchers from the University of Washington also found that wearing masks in public to prevent COVID-19 spread could save nearly 130,000 lives. → Read More

A 'Herculean' effort: States finalize their COVID-19 vaccine distribution plans

State public health departments say they’re ready to leap into action as soon as a COVID-19 vaccine is approved but caution much is still unknown. → Read More

Thanksgiving would be the earliest that a COVID-19 vaccine may arrive, Pfizer says

An open letter from the frontrunner COVID-19 vaccine producer published Friday ends any expectations a vaccine might be available before Election Day. → Read More

Herd immunity strategy endorsed by White House a 'ridiculous' way to stop COVID, say scientists — it will just kill people

Herd immunity, the idea that if enough people get a disease it will stop spreading, won't work for COVID-19, say scientists. Trump thinks it could. → Read More

Eli Lilly and Johnson & Johnson have paused COVID-19 vaccine trials. Why experts say that's reassuring, not frightening.

Experts say the recent pause on COVID-19 vaccine and treatment trials aren't unusual, but rather show scientific safety processes are working. → Read More

Johnson & Johnson pauses COVID-19 vaccine trial due to unexplained illness — the second US trial now on hold

The Phase 3 clinical trial was temporarily halted Monday because of an unexplained illness in one of the participants, Johnson & Johnson said. → Read More

President Donald Trump says COVID-19 vaccines are coming 'momentarily.' Scientists say they're not.

President Donald Trump said COVID-19 vaccines Are coming "momentarily." Doctors and scientists have repeatedly refuted that claim. → Read More

'Don't be afraid of it:' Donald Trump talks COVID-19 on video after return to White House

Trump issued a similar message in an afternoon tweet, drawing criticism from people who said he was being too nonchalant about the virus. → Read More

'Trying to reflect the upbeat attitude': How transparent does the president's doctor need to be?

Dr. Sean Conley adds doubt to the veracity of the reports being given by the White House and the president's medical staff. → Read More